Opaleye Management’s TRACON Pharmaceuticals TCON Stock Holding History
Bought
Maintained
Sold
Other funds holding TCON
Opaleye Management's TCON Position: Q4 2023 in Review
Opaleye Management sold out of TRACON Pharmaceuticals (TCON) in Q4 2023, closing a stake of 238,225 shares — an estimated $848K sold.
Opaleye Management first reported a position in TCON in Q1 2015 and held it in 14 quarters. The position peaked at $29.5M in Q4 2020. 24 funds tracked by Wall St. Rank hold TCON as of Q4 2023.
- Opaleye Management reported no remaining TRACON Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Opaleye Management sold 238,225 TRACON Pharmaceuticals shares in Q4 2023, an estimated $848K.
- Opaleye Management first reported a position in TRACON Pharmaceuticals in Q1 2015 and held it in 14 quarters.
- Opaleye Management's TRACON Pharmaceuticals position peaked at $29.5M in Q4 2020.
- 24 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q4 2023.
Based on Opaleye Management's 13F filing for Q4 2023, filed 14 Feb 2024.